The data generated during this fruitful collaboration with Prof. Langer’s lab and published in Nano Letters are very important for Curadigm. it represents an external validation of our concept to address the unmet needs of nucleic acid - based therapeutics. The potential of the Nanoprimer to improve treatment efficacy by avoiding liver clearance is a great opportunity to accelerate the development of RNA-based therapeutics and to bring a real benefit for the patients. […]